Results 81 to 90 of about 99 (98)
Cancer Communications, EarlyView.Abstract Background Diffuse large B‐cell lymphoma (DLBCL) is the most common subtype of aggressive non‐Hodgkin's lymphoma with distinct clinical and molecular heterogeneity. DLBCL that arises in extranodal organs is particularly linked to poor prognosis. This study aimed to determine the clinical and molecular characteristics of extranodal involvement (
Si‐Yuan Chen +46 more
wiley +1 more source
Three‐ to 4‐year follow‐up of the reverse palatal pedicle graft for maxillary palatal recessions
Clinical Advances in Periodontics, EarlyView.Abstract Background This study evaluates the long‐term stability and clinical outcomes of the reverse palatal pedicle graft (RPPG) technique in treating maxillary molar palatal recessions over a 3 to 4‐year follow‐up period. Methods Three patients with palatal recession defects on maxillary molars were treated using the RPPG technique.
Thomas T. Nguyen +2 more
wiley +1 more source
Crestal approach for repair of oroantral bone defects and subsequent implant placement
Clinical Advances in Periodontics, EarlyView.Abstract Background Oroantral communication (OAC) can occur after a dental extraction. Occasionally, bony defects may persist despite successful soft tissue closure of the OAC. The absence of bone in these areas poses challenges for dental implant placement.
Min Yang +3 more
wiley +1 more source
Guided transpositional bone blocks in esthetic zone: Surgical technique and case report
Clinical Advances in Periodontics, EarlyView.Abstract Background The ultimate objective of implant dentistry is to position the implant in a three‐dimensional, prosthetic‐driven location. This case highlights a guided approach for harvesting and positioning an autogenous bone block to restore a horizontal bone defect in the anterior maxilla.
Ming‐Fu Ye +5 more
wiley +1 more source
Chemistry &Biodiversity, EarlyView.This graphical abstract represents the extraction, characterization, and biological evaluation of bioactive compounds derived from specific plant sources. The top section illustrates Rhus coriaria (sumac) fruit, Punica granatum (pomegranate) peel and Terminalia catappa (Indian almond) leaves', which are known for their rich phytochemical composition ...
Mudassir Nazir +8 more
wiley +1 more source
ChemElectroChem, EarlyView.This review explores the transformative role of graphene derivatives in electrochemical biosensors for diagnostics, environmental monitoring, and industrial sensing. Highlighting innovations in synthesis and covalent functionalization, it discusses how these materials enhance biosensor stability, specificity, and scalability.
Petr Jakubec +8 more
wiley +1 more source
Laser‐Induced Graphene for Early Disease Detection: A Review
ChemElectroChem, Volume 12, Issue 6, March 15, 2025.Laser‐induced graphene (LIG) has emerged as a superior alternative to conventionally synthesized graphene due to its flexibility, cost‐effectiveness, scalability, high conductivity, and the ability to customize its properties for various applications. This review highlights LIG′s transformative potential in electrochemical biosensing, focusing on early
Sri Ramulu Torati, Gymama Slaughter
wiley +1 more source
Cutting‐Edge Aptasensing Approaches for Electrochemical Detection of Exosomes Utilizing MXenes
ChemElectroChem, EarlyView.This work notably summarizes research on 2D MXenes/MXene's‐hybrid‐based nanoplatforms patterned with aptamers as an alternative to antibodies affording highly sensitive and robust biosensing of exosomes as well as their efficient isolation. The exosomes are highlighted as a valuable source of biomarkers and with the immobilization approaches of ...
Andrej Vikartovský +5 more
wiley +1 more source
Estimating the Frequency of False‐Negative Pharmacogenetic Test Results by Self‐Reported Ancestry
Clinical Pharmacology &Therapeutics, EarlyView.Concerns about the applicability of pharmacogenetic (PGx) testing across diverse ancestry groups have risen from the underrepresentation of non‐European populations in PGx research. Current PGx panels may fail to detect relevant variants in non‐European populations, increasing the likelihood of false‐negative results.
Weng‐Sam Siu +7 more
wiley +1 more source
Clinical Pharmacology &Therapeutics, EarlyView.Barriers to incorporating pharmacogenetics into routine clinical practice in the United States are well documented. Initial surveys by the Clinical Pharmacogenetics Implementation Consortium (CPIC) in 2009 and 2010 identified barriers across four key domains that have hindered the widespread adoption of clinical pharmacogenetic testing.
D. Max Smith +18 more
wiley +1 more source